Journal of Asthma and Allergy

New Promising Treatments for Type 2 and Non-Type 2 Asthma

Although the hallmark of asthma pathobiology is airway inflammation, asthma is highly heterogeneous and is thus characterized by a variety of distinct symptoms supported by elaborate endotype networks of cellular and molecular systems. The goal of this Article Collection is to summarize recent developments pertaining to the inflammatory pathways underlying the phenotypes and endotypes of asthma. Clarifying the cellular and molecular targets of pharmacological therapies for this pervasive illness depends on ongoing work in this area.